147 related articles for article (PubMed ID: 34657068)
1. [A Case of Perforation of the Diverticulum of the Appendix during Chemotherapy with Ramucirumab plus Nab-Paclitaxel for Gastric Cancer].
Kurihara M; Sawazaki S; Kawabe T; Minowa K; Akimoto N; Tsuchiya K; Kato A; Higuchi A; Rino Y; Matsukawa H; Saeki H
Gan To Kagaku Ryoho; 2021 Oct; 48(10):1293-1295. PubMed ID: 34657068
[TBL] [Abstract][Full Text] [Related]
2. [A Case of Ramucirumab-Related Small Intestinal Perforation in Gastric Cancer].
Murase H; Oono R; Yoshida T; Ishihara K; Otomo M; Suzuki Y; Hayashi K; Higuchi K; Yoshinouchi S; Kamiya A; Obata M; Ogawa A; Hayashi M; Park S; Iseki H
Gan To Kagaku Ryoho; 2021 Dec; 48(13):1598-1600. PubMed ID: 35046268
[TBL] [Abstract][Full Text] [Related]
3. [A Case of Gastrointestinal Perforation in Gastric Cancer during Chemotherapy with Paclitaxel plus Ramucirumab].
Tanaka T; Ueda T; Sadamitsu T; Yokoyama T; Yoshimura A
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2240-2242. PubMed ID: 32156891
[TBL] [Abstract][Full Text] [Related]
4. [A Case of Perforation of the Duodenum during Chemotherapy with Ramucirumab plus Nab-Paclitaxel for Advanced Gastric Cancer].
Hanayama H; Suzuki H; Mochizuki S; Hayashishita S; Matsuishi A; Kanouda R; Maruyama Y; Kaneta A; Kikuchi T; Nirei A; Tada T; Saze Z; Kono K
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1636-1637. PubMed ID: 38303366
[TBL] [Abstract][Full Text] [Related]
5. [A Case of Advanced Gastric Cancer with Peritoneal Dissemination after Gastrectomy Successfully Treated with Paclitaxel plus Ramucirumab].
Miyamoto K; Tadano Y; Itoh R
Gan To Kagaku Ryoho; 2021 Jan; 48(1):113-114. PubMed ID: 33468738
[TBL] [Abstract][Full Text] [Related]
6. [A Case of Gastric Cancer with Ramucirumab-Related Colon Perforation after a Subtotal Colectomy].
Wada N; Akamaru Y; Hokkoku D; Wada R; Ikeshima R; Munakata K; Takiuchi D; Azama T; Morimoto O; Ota H; Kitada M; Shibata K
Gan To Kagaku Ryoho; 2019 Dec; 46(13):2066-2068. PubMed ID: 32157061
[TBL] [Abstract][Full Text] [Related]
7. [A Case of Advanced Gastric Cancer with Peritoneal Dissemination after Gastrectomy Effectively Treated with Combination Chemotherapy of Ramucirumab and Paclitaxel].
Muroya T; Wajima N; Kubo N; Yoshida E; Akaishi T; Umetsu S; Yoshida T; Wakasa Y; Sato K; Mitsuhashi Y; Umemura K; Ogasawara H; Hara Y; Hakamada K
Gan To Kagaku Ryoho; 2018 Dec; 45(13):2066-2068. PubMed ID: 30692286
[TBL] [Abstract][Full Text] [Related]
8. [Laparoscopic Partial Hepatectomy for the Liver Metastasis of Gastric Cancer after Nab-Paclitaxel plus Ramucirumab Combination Therapy-A Case Report].
Chuman M; Takahashi Y; Tokito T; Maruyama M; Chino S; Ushiku H; Nakamura K; Naito M; Kondo Y; Yamazaki H; Nishi Y; Hiki N
Gan To Kagaku Ryoho; 2020 Dec; 47(13):2065-2067. PubMed ID: 33468802
[TBL] [Abstract][Full Text] [Related]
9. [Salvage Surgery for Unresectable Advanced Esophagogastric Junction Carcinoma with Multiple Liver Metastases after Successful Second-Line Treatment with Nab-Paclitaxel and Ramucirumab Following a Refractory Response to S-1 plus CDDP Therapy-A Case Report].
Fujita T; Shimizu Y; Dongping F; Yamamoto N; Kobayashi M; Iwabu H; Tsuji A
Gan To Kagaku Ryoho; 2020 Nov; 47(11):1597-1600. PubMed ID: 33268735
[TBL] [Abstract][Full Text] [Related]
10. Successful Conversion Surgery for Advanced Gastric Cancer With Multiple Liver Metastases Following Ramucirumab Plus Paclitaxel Combination Treatment.
Namikawa T; Marui A; Yokota K; Fujieda Y; Munekage M; Uemura S; Maeda H; Kitagawa H; Kobayashi M; Hanazaki K
In Vivo; 2021; 35(5):2929-2935. PubMed ID: 34410989
[TBL] [Abstract][Full Text] [Related]
11. Retrospective comparison of nab-paclitaxel plus ramucirumab and paclitaxel plus ramucirumab as second-line treatment for advanced gastric cancer focusing on peritoneal metastasis.
Ishikawa M; Iwasa S; Nagashima K; Aoki M; Imazeki H; Hirano H; Shoji H; Honma Y; Okita N; Takashima A; Kato K; Saruta M; Boku N
Invest New Drugs; 2020 Apr; 38(2):533-540. PubMed ID: 31264067
[TBL] [Abstract][Full Text] [Related]
12. Weekly paclitaxel plus ramucirumab versus weekly nab-paclitaxel plus ramucirumab for unresectable advanced or recurrent gastric cancer with peritoneal dissemination refractory to first-line therapy-the P-SELECT trial (WJOG10617G)-a randomised phase II trial by the West Japan Oncology Group.
Hirata K; Hamamoto Y; Ando M; Imamura CK; Yoshimura K; Yamazaki K; Hironaka S; Muro K
BMC Cancer; 2020 Jun; 20(1):548. PubMed ID: 32532230
[TBL] [Abstract][Full Text] [Related]
13. [A Thoracic Aortic Dissection Case during Treatment with Ramucirumab plus Nab-Paclitaxel].
Nikai H; Akiyama Y; Fujisawa R; Endo F; Baba S; Koeda K; Sasaki A
Gan To Kagaku Ryoho; 2020 Jun; 47(6):981-983. PubMed ID: 32541179
[TBL] [Abstract][Full Text] [Related]
14. Effect of First-line S-1 Plus Oxaliplatin With or Without Ramucirumab Followed by Paclitaxel Plus Ramucirumab on Advanced Gastric Cancer in East Asia: The Phase 2 RAINSTORM Randomized Clinical Trial.
Yoshikawa T; Muro K; Shitara K; Oh DY; Kang YK; Chung HC; Kudo T; Chin K; Kadowaki S; Hamamoto Y; Hironaka S; Yoshida K; Yen CJ; Omuro Y; Bai LY; Maeda K; Ozeki A; Yoshikawa R; Kitagawa Y
JAMA Netw Open; 2019 Aug; 2(8):e198243. PubMed ID: 31373648
[TBL] [Abstract][Full Text] [Related]
15. Adjuvant albumin-bound paclitaxel combined with S-1 vs. oxaliplatin combined with capecitabine after D2 gastrectomy in patients with stage III gastric adenocarcinoma: a phase III multicenter, open-label, randomized controlled clinical trial protocol.
Cheng X; Wu D; Xu N; Chen L; Yan Z; Chen P; Zhou L; Yu J; Cui J; Li W; Wang C; Feng W; Wei Y; Yu P; Du Y; Ying J; Xu Z; Yang L; Zhang Y
BMC Cancer; 2021 Jan; 21(1):56. PubMed ID: 33435909
[TBL] [Abstract][Full Text] [Related]
16. [Long-Term Response of Nivolumab for Peritoneal Dissemination and Recurrent Liver Metastasis after Surgery for Perforated Gastric Cancer-A Case Report].
Kii S; Kuratani Y; Fujiyoshi S; Shimokuni T; Nishikawa M; Koike M; Takahashi M
Gan To Kagaku Ryoho; 2022 Dec; 49(13):1859-1861. PubMed ID: 36733023
[TBL] [Abstract][Full Text] [Related]
17. [Long-Term Survival of an Adolescent and Young Adult Patient with Unresectable Advanced Gastric Cancer in Whom Multidisciplinary Treatment Was Effective].
Namikawa T; Utsunomiya M; Yokota K; Kawanishi Y; Yamaguchi S; Munekage M; Maeda H; Kitagawa H; Nagata Y; Kobayashi M; Hanazaki K; Seo S
Gan To Kagaku Ryoho; 2023 Dec; 50(13):1985-1987. PubMed ID: 38303273
[TBL] [Abstract][Full Text] [Related]
18. [A Case of Recurrent Gastric Cancer with Grade 3 Proteinuria Caused by Ramucirumab plus Paclitaxel Therapy].
Kimura Y; Makari Y; Mikami J; Hiraki Y; Kato H; Iwama M; Shiraishi O; Yasuda A; Shinkai M; Imano M; Imamoto H; Fujita J; Furukawa H; Yasuda T
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1080-1082. PubMed ID: 29394540
[TBL] [Abstract][Full Text] [Related]
19. [A Case of Gastric Cancer with Peritoneal Dissemination Effectively Treated with Ramucirumab and Paclitaxel].
Seo S; Suzuki T; Misumi T; Tashiro H
Gan To Kagaku Ryoho; 2017 Nov; 44(12):1305-1307. PubMed ID: 29394615
[TBL] [Abstract][Full Text] [Related]
20. Treatment with Ramucirumab-paclitaxel in a metastatic gastric cancer patient undergoing hemodialysis: A case report.
Yang MJ; Choi YJ; Kim HJ; Kim DY; Seol YM
Medicine (Baltimore); 2021 Feb; 100(7):e24795. PubMed ID: 33607838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
